Are Brighter Days Ahead for This Fidelity Health Care Fund?
Health care stocks are showing signs of life after a lengthy period of underperformance. That bodes well for the Fidelity Select Health Care Portfolio.
After lagging the S&P 500 Index in each of the past three calendar years, health care stocks have outperformed the benchmark handily since the start of 2025, albeit with a slim loss.
The S&P 500 has declined 14% for the year to date through April 7; health care stocks have lost just 2%.
Our favorite health fund, the Fidelity Select Health Care Portfolio (FSPHX) – a member of the Kiplinger 25, the best no-load mutual funds – lags the sector index for the year to date. But over the past 12 months, the fund outpaced 65% of its peers despite a 6.9% loss.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Stakes in medical device companies advanced, including shares in Boston Scientific (BSX), as did certain biotech holdings, such as Alnylam Pharmaceuticals (ALNY).
What haven't done well are managed care companies, such as UnitedHealth Group (UNH). Uncertainty about government policy, particularly about Medicare, was a drag.
The other problem: Costs accelerated in 2024 for these firms thanks to inflation, says manager Ed Yoon, and government reimbursements for Medicare Advantage didn't keep pace.
Yoon favors companies with increasing demand for their products or services and improving free cash flow (money left over after operating expenses and spending to maintain or expand the business).
The recent good turn is a rebound after the sector's bad post-election results last year, says Yoon. In the last quarter of 2024, health care stocks sank 10% as the S&P 500 rose 2.4%.
"But the market feels like it's beginning to broaden out, and if that continues, it should bode well for the sector," he adds – before admitting he has said that before.
Still, things have changed in the health sector. While investors weren't looking, "innovation has progressed, and companies that weren't making money are now profitable. That can be a powerful driver for stock prices," Yoon says, adding that much of the sector's change has "gone unnoticed."
Since taking over as manager in 2008, Yoon has posted a 12.5% annualized return, which has outpaced the typical health fund and the S&P 500.
This item first appeared in Kiplinger Personal Finance Magazine, a monthly, trustworthy source of advice and guidance. Subscribe to help you make more money and keep more of the money you make here.
Related Content
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

Nellie joined Kiplinger in August 2011 after a seven-year stint in Hong Kong. There, she worked for the Wall Street Journal Asia, where as lifestyle editor, she launched and edited Scene Asia, an online guide to food, wine, entertainment and the arts in Asia. Prior to that, she was an editor at Weekend Journal, the Friday lifestyle section of the Wall Street Journal Asia. Kiplinger isn't Nellie's first foray into personal finance: She has also worked at SmartMoney (rising from fact-checker to senior writer), and she was a senior editor at Money.
-
December Fed Meeting: Live Updates and CommentaryThe December Fed meeting is one of the last key economic events of 2025, with Wall Street closely watching what Chair Powell & Co. will do about interest rates.
-
This Is Why Investors Shouldn't Romanticize BitcoinInvestors should treat bitcoin as the high-risk asset it is. A look at the data indicates a small portfolio allocation for most investors would be the safest.
-
I'm a Federal Benefits Pro: I Answer These 2 Questions a LotMany federal employees ask about rolling a TSP into an IRA and parsing options for survivor benefits, both especially critical topics.
-
December Fed Meeting: Live Updates and CommentaryThe December Fed meeting is one of the last key economic events of 2025, with Wall Street closely watching what Chair Powell & Co. will do about interest rates.
-
Why Investors Shouldn't Romanticize Bitcoin, From a Financial PlannerInvestors should treat bitcoin as the high-risk asset it is. A look at the data indicates a small portfolio allocation for most investors would be the safest.
-
I'm a Financial Pro Focused on Federal Benefits: These Are the 2 Questions I Answer a LotMany federal employees ask about rolling a TSP into an IRA and parsing options for survivor benefits, both especially critical topics.
-
Private Credit Can Be a Resilient Income Strategy for a Volatile Market: A Guide for Financial AdvisersAdvisers are increasingly turning to private credit such as asset-based and real estate lending for elevated yields and protection backed by tangible assets.
-
5 RMD Mistakes That Could Cost You Big-Time: Even Seasoned Retirees Slip UpThe five biggest RMD mistakes retirees make show that tax-smart retirement planning should start well before you hit the age your first RMD is due.
-
I'm a Wealth Adviser: My 4 Guiding Principles Could Help You Plan for Retirement Whether You Have $10,000 or $10 MillionRegardless of your net worth, you deserve a detailed retirement plan backed by a solid understanding of your finances.
-
A Retirement Triple Play: These 3 Tax Breaks Could Lower Your 2026 BillGood news for older taxpayers: Standard deductions are higher, there's a temporary 'bonus deduction' for older folks, and income thresholds have been raised.
-
If You're Retired or Soon-to-Be Retired, You Won't Want to Miss Out on These 3 OBBB Tax BreaksThe OBBB offers some tax advantages that are particularly beneficial for retirees and near-retirees. But they're available for only a limited time.